Date Initiated by Firm |
January 11, 2011 |
Date Posted |
March 07, 2011 |
Recall Status1 |
Terminated 3 on April 19, 2012 |
Recall Number |
Z-1572-2011 |
Recall Event ID |
57732 |
Product Classification |
Linear Medical Accelerator - Product Code IYE
|
Product |
MOSAIQ Oncology Information System
Intended Use : Electronic Patient Records Management |
Code Information |
Part # 10568605 |
Recalling Firm/ Manufacturer |
Siemens Medical Solutions USA, Inc 4040 Nelson Ave Concord CA 94520-1200
|
For Additional Information Contact |
Christine Dunbar 925-246-8407
|
Manufacturer Reason for Recall |
The potential for injury to a patient should the treatment data be incorrectly uploaded to patient records.
|
FDA Determined Cause 2 |
Software design (manufacturing process) |
Action |
Sent an Urgent Medical Device Correction Safety Advisory Notice to customers on 1/11/11. Letters will be delivered by Siemens Customer Service Group or sent by certified mail. Letter identified the affected product and stated there is a potential risk due to a problem identified by the manufacturer. Customers are asked to refer to the attached Safety Notice from Elekta IMPAC Software. A Siemens Service Engineer will contact customers site to arrange for a patient matching criteria audit to determine if you have a problem. Customers should include the Safety Advisory Notice including the Safety Notice from Elekta IMPAC Software in their product related documentation until further notice. If customers have any questions, they should contact their responsible SIEMENS Service Engineer or Application Specialist. |
Quantity in Commerce |
10 units |
Distribution |
International Only Distribution -- Germany and Japan |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|